Page 8 - Repligen Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alyeska Investment Group L.P. acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 398,003 shares of the biotechnology company’s stock, valued at approximately $67,008,000. Alyeska Investment Group L.P. owned about […]

Stephens Investment Management Group LLC reduced its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 3.2% during the first quarter, Holdings Channel.com reports. The institutional investor owned 528,464 shares of the biotechnology company’s stock after selling 17,490 shares during the quarter. Repligen accounts for about 1.5% of Stephens Investment Management Group LLC’s investment portfolio, […]

Stephens Investment Management Group LLC decreased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 3.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 528,464 shares of the biotechnology company’s stock after selling 17,490 shares […]

Cerity Partners LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 333.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,929 shares of the biotechnology company’s stock after buying an additional 6,100 shares during the period. Cerity Partners LLC’s holdings […]

Wellington Management Group LLP grew its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 79.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,493,551 shares of the biotechnology company’s stock after buying an additional 662,807 shares during the quarter. Wellington Management […]